Ignite Creation Date:
2025-12-24 @ 2:06 PM
Ignite Modification Date:
2026-01-31 @ 5:51 PM
Study NCT ID:
NCT00096395
Status:
COMPLETED
Last Update Posted:
2013-06-13
First Post:
2004-11-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer
Sponsor:
Organization: